Summary
Shukra Pharmaceuticals share holding pattern reports the following shareholding: Shukra Pharmaceuticals Total Promoters is at 50.96%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.11%, and Retail at 48.93%. This breakdown provides a quick snapshot of ownership distribution for Shukra Pharmaceuticals share holding pattern in 2026-27.
Shukra Pharmaceuticals FAQs
As of 05-2026, the promoter shareholding in Shukra Pharmaceuticals stands at 50.96% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Shukra Pharmaceuticals is 0% and 0.11% respectively.
The retail shareholding of the Shukra Pharmaceuticals is 48.93%.
Changes in shareholding patterns of Shukra Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Shukra Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Shukra Pharmaceuticals Associated Pages
- Shukra Pharmaceuticals Share Price
- Shukra Pharmaceuticals Share Price chart
- Shukra Pharmaceuticals Fundamental Analysis
- Shukra Pharmaceuticals Technical Analysis
- Shukra Pharmaceuticals Peer Comparison
- Shukra Pharmaceuticals Share Price History
- Shukra Pharmaceuticals Stock Split
- Shukra Pharmaceuticals Dividend
- Shukra Pharmaceuticals Board of Directors
